P
LLY icon

Palladiem’s Eli Lilly LLY Stock Holding History

Palladiem’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$376K Buy
394
+31
+9% +$31.4K 0.36% 31
2025
Q4 		$391K Buy
+363
New +$347K 0.37% 28
2015
Q3 		$15K Hold
178
– – 0.02% 80
2015
Q2 		$15K Hold
178
– – 0.01% 108
2015
Q1 		$13K Hold
178
– – 0.01% 106
2014
Q4 		$12K Buy
+178
New +$12K 0.01% 118

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Palladiem's LLY Position: Q1 2026 in Review

Palladiem increased its Eli Lilly (LLY) stake by 8.5% in Q1 2026, buying an estimated $31.4K and bringing the position to 394 shares worth $376K. The position accounts for 0.36% of the portfolio, ranked #31.

Palladiem first reported a position in LLY in Q4 2014 and has held it in 6 quarters since. The position peaked at $391K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Palladiem held 394 shares of Eli Lilly worth $376K as of Q1 2026.
  • Palladiem bought 31 Eli Lilly shares in Q1 2026, an estimated $31.4K.
  • Eli Lilly made up 0.36% of Palladiem's portfolio in Q1 2026, its #31 holding.
  • Palladiem first reported a position in Eli Lilly in Q4 2014 and has held it in 6 quarters since.
  • Palladiem's Eli Lilly position peaked at $391K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Palladiem's 13F filing for Q1 2026, filed 6 May 2026.